Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AYP-101 for submental fat reduction
NCT06256445Phase 3Completed
- Sponsor
- AMIpharm
- Start
- Mar 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of polyene phosphatidylcholine, sponsored by AMIpharm. Started Mar 2024; status: completed.
02
Drugs
polyene phosphatidylcholine
Beyond the preview
Go deeper on NCT06256445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06256445.